4//SEC Filing
Lin Tai-An 4
Accession 0001104659-23-106819
CIK 0001773427other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:18 PM ET
Size
7.6 KB
Accession
0001104659-23-106819
Insider Transaction Report
Form 4
Lin Tai-An
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-10-02+75,000→ 75,000 totalExercise: $22.80Exp: 2033-10-02→ Common Stock (75,000 underlying) - Award
Common Stock
2023-10-02+24,000→ 24,000 total
Footnotes (2)
- [F1]This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty three percent (33%) to vest on October 2, 2024, another thirty three percent (33%) to vest on October 2, 2025 and the remaining thirty four percent (34%) to vest on October 2, 2026, such that the restricted stock awards are fully vested on October 2, 2026, subject to continued service to the Issuer by the Reporting Person.
- [F2]Twenty-five percent (25%) of this option shall vest and become exercisable on October 2, 2024, with the remaining seventy-five percent (75%) to vest in thirty-six (36) equal monthly installments thereafter, subject to continued service to the Issuer by the Reporting Person.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001991985
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:18 PM ET
- Size
- 7.6 KB